[Lipoprotein (a) and XXXX ].

@entity2175 @entity1 @entity455 @entity6 @entity301 @entity3452 @entity177 @entity1723 @entity989 @entity413 @entity731 @entity65
@entity3452 has atherogenic and thrombotic properties and is considered to be a major risk factor for the development of @entity731 . The risk of @entity65 is increased in both insulin-dependent ( @entity1723 ) and @entity2175 ( @entity2175 ), and @entity3452 has attracted attention as a potential risk factor in @entity6 @entity1 . @entity3452 levels are "probably" elevated in @entity1723 @entity1 and related to altered metabolic control and increased urinary albumin excretion rate or @entity177 , although results are controversial. There appears to be a real difference between the @entity3452 of @entity1 with @entity6 and those with or without background @entity989 . The plasma @entity3452 level may therefore be associated with @entity455 in some @entity1723 @entity1 . However, data relating @entity3452 to complications of @entity6 are limited, and the literature is conflicting. The few available data suggest that @entity3452 is not elevated in @entity2175 @entity1 and that there is no strong link between blood @entity413 control and plasma @entity3452 . There is no clear evidence as to whether @entity3452 is related to microalbuminuria in @entity2175 @entity1 . There is little evidence for a correlation between increased risk of @entity65 and plasma @entity3452 among @entity6 @entity1 . However, some @entity6 @entity1 with @entity301 have elevated plasma @entity3452 , which seems to be correlated with genetic factors (especially the isoforms of apolipoprotein a) rather than to @entity6 per se. @entity3452 synthesis and catabolism could be influenced by insulin or by @entity6 and its metabolic concomitants. The atherogenic and thrombogenic potential of @entity3452 could also be increased in @entity6 @entity1 . Plasma @entity3452 should be measured for both @entity1723 and @entity2175 @entity1 . If the @entity3452 level is elevated, it seems reasonable to check the other major vascular risk factors.
